SHOWME-PAD (Peripheral Artery Disease)
Key facts
- Where
- Kansas City, United StatesSee the site
Where in United States
- Saint Luke's Hospital of Kansas CityKansas City, United StatesNo longer taking part
Trial details
- Who runs it
- Saint Luke's Health System
- Trial code
- NCT03190382
- Record updated
- 24 May 2024
- Original description
The overall goal of SHOWME-PAD is to make the existing evidence-base on treatment outcomes -focusing on health status outcomes that reflect the patients' perspective - more transparently available to patients and providers, such that more informed, evidence-based shared treatment decisions occur. INTEGRITY-PAD has the potential to radically reorganize care delivery to patients with PAD such that more value for the patient and society will be created.Read full original descriptionShow less
SHOW-ME PAD (Peripheral Artery Disease)
The overall goal of SHOWME-PAD is to make the existing evidence-base on treatment outcomes -focusing on health status outcomes that reflect the patients' perspective - more transparently available to patients and providers, such that more informed, evidence-based shared treatment decisions occur. INTEGRITY-PAD has the potential to radically reorganize care delivery to patients with PAD such that more value for the patient and society will be created.
Inclusion: All race and ethnicity categories, English speaking, men and women; Age ≥18 years; New onset complaints of PAD symptoms or exacerbation of previous PAD symptoms; The diagnostic enrollment criterion includes a positive result for one of the following; Doppler resting ankle-brachial index (ABI)≤0.90 or a significant drop in post exercise ankle pressure of ≥20 mmHg; Duplex; CTA; MRA; TCOM; Angiogram.
Exclusion: A lower limb revascularization procedure in the ipsilateral leg (same leg) where the patient is currently having symptoms in the past year (atherectomy, endarterectomy, bypass surgery, angioplasty); Patients with dementia; Non-compressible ankle-brachial index (ABI ≥ 1.30); Peripheral intervention that occurs before the baseline interview; Current episode of critical limb ischemia (ischemic rest pain, ulceration or gangrene) (Fontaine III, IV or Rutherford IV-VI); Patients who are prisoners; Patients who are unable to provide informed consent; Non-English speaking patients.